Wynn Capital, LLC Novo Nordisk A S Transaction History
Wynn Capital, LLC
- $168 Billion
- Q1 2025
A detailed history of Wynn Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wynn Capital, LLC holds 7,090 shares of NVO stock, worth $468,365. This represents 0.29% of its overall portfolio holdings.
Number of Shares
7,090
Previous 7,045
0.64%
Holding current value
$468,365
Previous $606 Million
18.76%
% of portfolio
0.29%
Previous 0.38%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,880Shares Held
337MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.32 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.02 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$858 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$835 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$806 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $149B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...